comparemela.com

Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Stock analysts at Capital One Financial dropped their Q2 2024 earnings per share estimates for Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will post earnings of ($0.28) per share for the quarter, […]

Related Keywords

United States ,America ,Brian Mckelligon ,Akoya Bioscience ,Asia Pacific ,Akoya Biosciences ,Asset Management Inc ,Canaccord Genuity Group ,Nisa Investment Advisors ,York Mellon Corp ,Akoya Biosciences Inc ,Tower Research Capital ,Nasdaq ,Akoya Biosciences Company Profile ,Jpmorgan Chase Co ,Schonfeld Strategic Advisors ,Free Report ,Capital One Financial ,One Financial ,Get Free Report ,Biosciences Stock Down ,Investment Advisors ,Research Capital ,Management Inc ,Strategic Advisors ,New York Mellon Corp ,North America ,Middle East ,Akoya Biosciences Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.